Visionary Horizons’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$727K Sell
4,636
-44
-0.9% -$6.6K 0.3% 56
2026
Q1
$715K Buy
4,680
+10
+0.2% +$1.53K 0.35% 51
2025
Q4
$644K Sell
4,670
-160
-3% -$21K 0.33% 58
2025
Q3
$619K Sell
4,830
-290
-6% -$35.4K 0.35% 59
2025
Q2
$620K Sell
5,120
-240
-4% -$27.1K 0.39% 53
2025
Q1
$598K Sell
5,360
-720
-12% -$76.7K 0.42% 48
2024
Q4
$592K Sell
6,080
-180
-3% -$19.2K 0.39% 46
2024
Q3
$720K Sell
6,260
-40
-0.6% -$4.54K 0.48% 32
2024
Q2
$671K Sell
6,300
-5
-0.1% -$502 0.49% 29
2024
Q1
$590K Sell
6,305
-265
-4% -$27.2K 0.46% 35
2023
Q4
$663K Buy
+6,570
New +$634K 0.54% 27

Other funds holding NVS

Visionary Horizons's NVS Position: Q2 2026 in Review

Visionary Horizons reduced its Novartis (NVS) stake by 0.94% in Q2 2026, selling an estimated $6.6K and leaving 4,636 shares worth $727K. The position accounts for 0.3% of the portfolio, ranked #56.

Visionary Horizons first reported a position in NVS in Q4 2023 and has held it in 11 quarters since. 733 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Visionary Horizons held 4,636 shares of Novartis worth $727K as of Q2 2026.
  • Visionary Horizons sold 44 Novartis shares in Q2 2026, an estimated $6.6K.
  • Novartis made up 0.3% of Visionary Horizons's portfolio in Q2 2026, its #56 holding.
  • Visionary Horizons first reported a position in Novartis in Q4 2023 and has held it in 11 quarters since.
  • 733 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Visionary Horizons's 13F filing for Q2 2026, filed 16 Jul 2026.